Quest Laboratories logo

Quest Laboratories

QUESTLAB NSE

Key Fundamentals

SMEPharmaceuticalsHealthcare
Market Cap
₹138 Cr
Volatility
Moderate
P/E Ratio
9.25
EBITDA
₹18.24 Cr
Return on Equity
16.58%
Debt to Equity
0.08
Book Value
₹59.08
52W High
₹152.6
52W Low
₹81.3

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

4
  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 86.8% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 23.2%

Weaknesses

2
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Working capital days have increased from 129 days to 258 days

Growth Rate

Revenue Growth
3.35% lower than 3Y
Net Income Growth
7.43% lower than 3Y
Cash Flow Change
-875% lower than 3Y
ROE
-52.91% lower than 3Y
ROCE
-53.8% lower than 3Y
EBITDA Margin (Avg.)
-14.66% higher than 3Y

Quarterly Results

Particulars Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales
15.25
27.37
14.84
46.45
23.18
25.62
30.61
32.4
Expenses
13.47
18.56
14.18
45.64
19.36
22.24
23.7
28.26
Operating Profit
1.78
8.81
0.66
0.81
3.82
3.38
6.91
4.14
OPM %
11.67%
32.19%
4.45%
1.74%
16.48%
13.19%
22.57%
12.78%
Other Income
0.16
0.68
0.3
3.41
1.85
1.42
0.57
-1.31
Interest
0.13
0.37
0.04
0.37
0.64
0.58
0.47
0.16
Depreciation
0.15
0.14
0.15
0.19
0.21
0.21
0.2
0.21
PBT
1.66
8.98
0.77
3.66
4.82
4.01
6.81
2.46
Tax %
11.45%
32.41%
0%
47.27%
14.94%
0%
40.82%
-16.67%
Net Profit
1.48
6.06
0.78
1.94
4.1
4.02
4.03
2.87
EPS in Rs
0.9
3.7
0.48
1.18
2.5
2.45
2.46
1.75
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales
30
59
62
83
104
112
Expenses
29
53
54
67
88
94
Operating Profit
1
6
8
16
16
18
OPM %
4.7%
11%
13%
19%
15%
16%
Other Income
0
0
0
0
4
3
Interest
0
0
1
1
1
2
Depreciation
0
0
1
1
1
1
PBT
1
6
7
14
19
18
Tax %
18%
29%
28%
30%
27%
17%
Net Profit
1
4
5
10
14
15
EPS in Rs
—
—
—
8.45
8.28
9.17
Div. Payout %
0%
0%
0%
0%
0%
0%
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
1
1
1
12
16
16
Reserves
5
9
14
17
65
80
Borrowings
3
3
4
5
30
8
Other Liabilities
9
22
28
27
10
6
Total Liabilities
18
35
47
61
122
111
Fixed Assets
6
7
10
10
12
15
CWIP
0
0
0
0
0
1
Investments
0
0
0
7
52
16
Other Assets
12
27
37
44
58
79
Total Assets
18
35
47
61
122
111
Figures in ₹ Crores

Cash Flow

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
1
3
4
3
-23
-11
Investing
-1
-2
-4
-5
-44
35
Financing
0
0
0
2
67
-24
Net Cash Flow
0
1
0
0
0
0
Free Cash Flow
0
2
1
2
-27
-16
CFO/OP
103
57
72
46
-120
-34
Figures in ₹ Crores

Ratios

Particulars Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
110
135
118
108
105
118
Inventory Days
12
9
97
113
99
163
Days Payable
119
140
215
144
26
24
Cash Conversion Cycle
3
4
1
77
178
258
Working Capital Days
9
14
27
58
72
258
ROCE %
—
55%
47%
57%
27%
18%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Quest Laboratories insights

58 extracted metrics + investor summaries across FY21–FY26.

Log in — free

Shareholding Pattern

FIIs0.61%Promot.66.78%DIIs2.04%Others3.58%Public26.98%As ofMar 2026

Documents

Frequently Asked Questions about Quest Laboratories

What does Quest Laboratories Ltd do?
Incorporated in 1998, Quest Laboratories Ltd is a pharmaceutical manufacturer specializing in diverse therapeutic segments[1]
Where is Quest Laboratories Ltd (QUESTLAB) listed?
Quest Laboratories Ltd trades as QUESTLAB on the NSE.
Which sector does Quest Laboratories Ltd belong to?
Quest Laboratories Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Quest Laboratories Ltd?
Quest Laboratories Ltd has a market capitalisation of ₹137.57 Cr, which places it in the Small Cap band.
What is the PE ratio of Quest Laboratories Ltd?
Quest Laboratories Ltd trades at a PE ratio of 9.25, against a book value of ₹59.08 per share.
What is the 52-week high and low of Quest Laboratories Ltd?
Over the last 52 weeks Quest Laboratories Ltd has traded between ₹81.3 and ₹152.6.
What is the Return on Equity (ROE) of Quest Laboratories Ltd?
Quest Laboratories Ltd reported a return on equity of 16.58%. Its debt-to-equity ratio is 0.08.

Company Information

Incorporated in 1998, Quest Laboratories Ltd is a pharmaceutical manufacturer specializing in diverse therapeutic segments[1]

Website questlabltd.com
Listed 2024-05-23
Face Value ₹ 10
Issued Size 1,63,87,200

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/QUESTLAB.md for Quest Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List